WM
Weican Medical
China · Healthtech
Weican Medical develops implantable vascular-access and drug-delivery devices.
Product
Weican Medical develops implantable devices that provide access for delivering medicines. Its work combines clinical experience with mechanical design, materials engineering and medical-device development.
Founded in Nanjing in 2023, the company focuses on minimally invasive implanted ports and related drug-delivery technology. It works with university research teams to advance its devices from research toward clinical use.
Funding history
1 round · 0 with disclosed amounts| Announced | Round | Amount | Investors |
|---|---|---|---|
| Financing | Undisclosed | Dongnan Fund — ParticipantNuoyu Capital — Participant |
Investors
Dongnan FundJoined FinancingNuoyu CapitalJoined FinancingCoverage
Mar 1, 2026Weican Medical · FinancingSimilar companies
BMBoston Medical SciencesBoston Medical Sciences develops AI-assisted colorectal cancer screening technology.¥5.6B · Series B
TFTOKI Fund ITOKI Fund I backs Japanese seed-stage startups, with a focus on advanced medicine and content.Undisclosed · LP commitment
LABTECHSLABTECHS develops rapid sterility testing kits and reagents from research at the University of Toyama.Undisclosed · T-CAF investment commitment